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Identifying molecular targets that are able to buffer the consequences of stress and 
therefore restore brain homeostasis is essential in order to develop treatments for 
stress-related disorders. Down-regulated in renal cell carcinoma 1 (DRR1) is a 
unique stress-induced protein in the brain and has been recently proposed to 
modulate stress resilience. Interestingly, DRR1 shows a prominent expression in the 
limbic system of the adult mouse. 
Here we analyzed the neuroanatomical and cellular expression patterns of DRR1 in 
the adult mouse brain using in situ hybridization, immunofluorescence and western 
blot. Abundant expression of DRR1 mRNA and protein was confirmed in the adult 
mouse brain with pronounced differences between distinct brain regions. The 
strongest DRR1 signal was detected in the neocortex, the CA3 region of the 
hippocampus, the lateral septum and the cerebellum. DRR1 was also present in 
circumventricular organs and its connecting regions. Additionally, DRR1 was present 
in non-neuronal tissues like the choroid plexus and ependyma. Within cells, DRR1 
protein was distributed in a punctate pattern in several subcellular compartments 
including cytosol, nucleus as well as some pre- and postsynaptic specializations. 
Glucocorticoid receptor activation (Dexamethasone 10mg/kg s.c.) induced DRR1 
expression throughout the brain, with particularly strong induction in white matter and 
fiber tracts and in membrane rich-structures.  
This specific expression pattern and stress modulation of DRR1 point to a role of 
DRR1 in regulating how cells sense and integrate signals from the environment and 





Stress induces a plethora of molecular changes in the brain aimed at facilitating 
individual adaptation to new environmental demands. However, in individuals at risk, 
stress can trigger deleterious consequences on neuronal function through 
mechanisms that are not fully understood (de Kloet et al. 2005; Popoli et al. 2012; 
Sousa and Almeida 2012; Duman et al. 2016). Glucocorticoid receptor (GR) 
activation induces gene transcription and mediates some -but not all- of the long term 
effects of stress. GR-mediated mechanisms are prominent in late phase response to 
stress (slow stress-induced changes) and appear to be involved in homeostasis 
restoration and consolidation of relevant information for future use (de Kloet et al. 
2005; Yau and Seckl 2012). Thus, the characterization of GR targets responsible for 
restoring homeostasis and attenuating the negative consequences of stress is a 
promising route for the development of treatments for stress-related disorders.  
The stress-inducible down-regulated in renal cell carcinoma 1 (DRR1, also known as 
TU3A and Fam107A) was initially identified as a putative tumor suppressor gene in 
renal cell carcinoma (Yamato et al. 2000; Wang et al. 2000), then as unique gene 
increased in both psychiatric and neurodegenerative disorders (Shao and Vawter 
2008; Li et al. 2014; Shin et al. 2016) and recently pointed as a novel molecular 
player promoting stress resilience (Masana et al. 2014, 2015; van der Kooij et al. 
2016), supporting the involvement of DRR1 in modulating neuronal function under 
pathophysiological conditions. Interestingly, DRR1 is an actin-interacting protein and 
during recent years, neuronal actin dysfunction has been suggested as a potential 
shared pathological mechanism in neurodevelopmental disorders (van der Kooij et al. 
2016; Yan et al. 2016). 
 
GR activation increases DRR1 gene expression in stress-relevant brain regions such 
as the hypothalamic paraventricular nucleus and the hippocampal CA3 region (Liebl 
et al. 2009; Schmidt et al. 2011), lateral septum (Masana et al. 2014) and prefrontal 
cortex (Stankiewicz et al. 2014). Virus-induced overexpression of DRR1 in these 
brain regions improves cognitive performance (Schmidt et al. 2011) and increases 
social behavior (Masana et al. 2014), suggesting that DRR1 facilitate specific 
behaviors which might be protective against some of the deleterious consequences 
of stress exposure. 
Interestingly, DRR1 protein is strongly conserved among species (Zhao et al. 2007; 
Schmidt et al. 2011) and particularly involved in the development of the nervous 
system (Pankratz et al. 2007; Zhao et al. 2007; Asano et al. 2010). During mouse 
embryonic development, DRR1 is expressed in axonal projections of the central and 
peripheral nervous system (Asano et al. 2010). The neuroanatomical DRR1 mRNA 
distribution examined so far in the adult mouse brain reveals a distinct spatial DRR1 
expression pattern (Schmidt et al. 2011). However, an exhaustive characterization of 
DRR1 expression in the adult mouse brain has not been conducted so far.  
In the present study, we aimed to (1) thoroughly characterize DRR1 mRNA and 
protein expression pattern in the adult mouse brain and (2) to identify in which brain 




MATERIALS AND METHODS  
 
Animals 
Male C57/Bl6N mice (Charles River Laboratories) (>12 weeks old) were used for all 
experiments. Animals were single housed and kept on a 12-h light/dark cycle (lights 
on at 7:00 AM), at room temperature of 23 ± 2°C, with food and water provided ad 
libitum. All efforts were made to minimize animal suffering during the experiments. All 
experiments were carried out in the animal facilities of the Max Planck Institute of 
Psychiatry in Munich, Germany. 
 
Dexamethasone treatment 
Dexamethasone-21-dihydrogen-phosphate disodium salt (DEX) (Fortecortin®-inject 
100mg (10 ml), Merck Pharma GmbH, Germany), a potent synthetic agonist of the 
glucocorticoid receptor, was diluted to a final concentration of 2mg/ml with 0,9% 
saline and injected sub-cutaneously (s.c.) with a single dosage of 10 mg/kg body 
weight between 8-9 am (~130l). Vehicle-treated animals (Veh, control) were injected 
with the corresponding volume of 0.9% saline. All animals were sacrificed 8 h post 
injection under isoflurane anesthesia, trunk blood samples collected for 
corticosterone levels assessment using a radioimmuno assay kit (MP Biomedicals 
Inc; sensitivity 6.25 ng/ml) as previously described (Wagner et al. 2011), and brains 
processed for in situ hybridization and western blot analysis. Three batches of 
animals were used. First batch (n=6 Vehicle; n=6 DEX): one brain hemisphere was 
used for hippocampal total protein extraction and analysis, the other for in situ 
hybridization. Second batch (n=6 Vehicle; n=6 DEX): both hippocampi were 
dissected and subjected to subcellular fractionation for protein analysis (cytosol, 
membrane, nuclei, cytoskeleton). Third batch: 6 hippocampi pools/group (4 mice 
hippocampi/pool) were used for subcellular fractionation.  
 
In situ hybridization 
In situ hybridization was performed as previously reported (Schmidt et al. 2011; 
Masana et al. 2014, 2015). Brains were quickly removed, frozen in isopentane and 
stored at -20°C. Sections were cut at 18 μm using a cryostat microtome, thaw-
mounted on Superfrost plus slides (Menzel Gläser, Germany), and stored at -20°C. 
The antisense cRNA hybridization probe was 486 bp long, covering exons 1–4 
(forward primer: GTGGAGGGAAGGAGAAGGAC; reverse primer: 
TCCCGGACTTTGATGAACTC) and using Basic Local Alignment Tool (BLAST, 
NCBI, NIH) optimized for both highly similar sequences (megablast) and more 
dissimilar sequences (discontiguous megablast), indicate that our riboprobe would 
only bind to one transcript corresponding to DRR1. The intensity of the DRR1 mRNA 
expression has been shown to increase in virus-mediated DRR1 overexpression 
(Schmidt et al. 2011; Masana et al. 2014). Sections were fixed in 4% 
paraformaldehyde, acetylated in 0.25% acetic anhydride and dehydrated in 
increasing concentrations of ethanol. Each slide was exposed to 100µl of 
hybridization buffer containing 3-5 x 106cpm [35S] labeled riboprobe, coverslipped 
and incubated overnight at 55°C. The next day, sections were rinsed in 2x standard 
saline citrate (SSC), treated with RNAse A (20 mg/l) at 37°C and washed in 
decreasing SSC concentration solutions at room temperature. Then, sections were 
washed in 0.1×SSC for 1h at 65ºC and dehydrated through increasing concentrations 
of ethanol. Finally, slides were exposed to Kodak Biomax MR films (Eastman Kodak 
Co., Rochester, NY), developed and the autoradiographs digitized. For increased 
resolution of the neuroanatomical expression pattern of DRR1 mRNA a silver grain 
staining was performed. Sections were dipped in Kodak NTB emulsion (Eastman 
Kodak Co., Rochester, NY), exposed for 3 days at 4°C, and then developed in Kodak 
D19 solution. The developed slides were lightly counterstained with cresyl violet.  
 
Immunofluorescence 
Immunofluorescence staining’s were performed as previously described (Schmidt et 
al. 2011; Masana et al. 2014). Animals were deeply anesthetized with 
ketamin/rompun and perfused intracardially with 4 % paraformaldehyde; brains were 
removed, post fixed overnight in 4% paraformaldehyde following overnight incubation 
in 20 % sucrose solution at 4°C, frozen in isopentane at -40°C. All brain tissue was 
subsequently stored at -20°C/-80°C until use. Free-floating sections were cut at 30 
μm using a cryostat microtome, thaw-mounted on Superfrost slides (Menzel Gläser, 
Germany) and stored at -20°C until immunofluorescence staining was performed. 
Phosphate buffer 0.1M (PB) was used for all washing steps, and all reagents were 
diluted in PB. Sections were washed in 0.3% Triton-X100, blocked for 1 hour in 5% 
normal donkey serum (Abcam) in 0.3% Triton-X100, and incubated with the primary 
antibodies overnight at 4°C. Sections were washed and incubated for 2 hours with 
AlexaFluor conjugated secondary antibodies (1:500) at room temperature, and 
washed again. Then, rinsed in distilled water, mounted on superfrost plus slides, and 
covered with Vectashield mounting medium (Vector Laboratories, Burlingame, USA) 
containing DAPI. The rabbit polyclonal antibody against DRR1 was produced by 
Biogenes (Berlin, Germany) using recombinant DRR1 in rats and affinity-purified 
(with the same antigen) (Schmidt et al. 2011) and it has been used for Western 
blotting and immunstaining before (Masana et al, 2014; Schmidt et al, 2011). While 
there is no DRR1-knock-out available, the specificity of the antibody had been 
assessed as follows: 1. In western blot analyses, the antibody recognizes 
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recombinant DRR1, as well as DRR1 in extracts from cells transfected to express 
DRR1 and from brain tissue expressing DRR1 (Schmidt et al, 2011). 2. The intensity 
of the DRR1 protein expression by immunofluorescence increases in virus-mediated 
overexpression (Schmidt et al. 2011; Masana et al. 2014);. aAlso mouse anti-
Neuronal Nuclei (NeuN) (1:500; Millipore); Goat anti-Synaptophysin (1:250; 
SantaCruz); Goat anti-PSD-95 (1:500; Abcam) and the appropriate secondary 
antibodies linked to Alexa Fluor 488/555/647 (Invitrogen) were used. 
 
Image acquisition and analysis 
Silver grain stainings of in situ hybridization were examined using an Axioskop2 
microscope and photomicrographs were taken with Axiovision software (Zeiss, Jena, 
Germany). Images of immunofluorescence stainings were obtained with a laser-
scanning confocal microscope (IX81-FV1000, Olympus, Tokyo, Japan) using 
Olympus FV10-ASW 2.0 software. All images were processed with the FIJI software 
(Schindelin et al. 2012). Representative images were adjusted for brightness and 
contrast. Overview figures were created from 16-30 single images using the MosaicJ 
plugin (Thévenaz and Unser 2007). The different anatomical brain regions were 
identified with the mouse brain atlas (Paxinos and Franklin 2008). Signal intensities 
were rated into one of the following categories: - not detectable, + weak signal, ++ 
moderate signal and +++ strong signal, according to the grey intensity levels in the 
autoradiograph and also the expression observed in the high resolution 
photomicrographs of [35S]-labelled DRR1 mRNA.  
 
1.1. Western blot 
For total protein detection, hippocampi were dissected and frozen on dry ice, 
homogenized in 100 l ice cold lysis buffer (50mM Tris/HCl, 250mM Sucrose, 1mM 
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EDTA, 1:100 protease inhibitor cocktail P2714 (Sigma Aldrich), pH adjusted to 7.5), 
centrifuged 10 min at 8000rpm, the supernatant was centrifuged again 10 min at 
7000rpm, at 4°C. Cytosol (F1), membranes (F2), nuclear (F3) and cytoskeletal (F4) 
fractions were separated using a commercially available kit (ProteoExtract® 
Subcellular Proteome Extraction Kit, Calbiochem, 539790). Protein concentrations 
were determined using a detergent compatible protein assay kit (Bio-Rad, Hercules, 
CA, USA). Samples containing 40 µg of protein were resolved by 15% sodium 
dodecyl sulphate–polyacrylamide gels, and transferred onto nitrocellulose 
membranes (GE Healthcare). 
A second subcellular separation was done according to the protocol described in 
(Gardoni et al. 2006; Treccani et al. 2014). Each pool of tissue was homogenized in 
0.32 M ice-cold sucrose containing (in mM): 1 HEPES, 1 MgCl2, 1 EDTA, 1 
NaHCO3, and 0.1 PMSF, at pH 7.4, with a complete set of proteases inhibitors 
(Complete; Roche Diagnostics, Basel, Switzerland) and phosphatases inhibitors 
(Sigma, St. Louis, MO). The hippocampi homogenate was centrifuged 10 min at 
1000g. The obtained supernatant (S1) was centrifuged 15min at 3000g. The cytosol 
fraction was obtained (S2 fraction) and the pellet (P2 fraction, crude membrane 
fraction) was resuspended in 1 mM HEPES plus CompleteTM in a glass–glass potter 
and centrifuged 1h at 100,000g. The pellet (P3 fraction) was resuspended in buffer 
containing 75 mM KCl and 1% Triton X-100 and centrifuged 1h at 100,000g. The 
supernatant (S4 fraction, Triton X-100-soluble fraction (TSF)) was obtained and the 
final pellet (P4 fraction, TIF) was homogenized in a glass–glass potter in 20 mM 
HEPES, an equal volume of glycerol was added and stored at −80°C until 
processing. 
Membranes were labeled with rabbit anti-DRR1 (1:2000, BioGenes), goat anti-actin 
(1:2000, Santa Cruz Biotechnology), rat anti-tubulin (1:5000, Abcam) antibodies 
overnight at 4°C. Following incubation with the corresponding horseradish 
peroxidase-conjugated (1:2000, DAKO) secondary antibodies for 3h. Bands were 
visualized using an enhanced chemiluminescence system (Millipore), detected using 
the Chemidoc system (BioRad) and quantified by densitometry (Image Lab Software, 
Bio-Rad). Duplicates of each sample were loaded and measured independently.. 
 
1.2. Statistical Analysis 
The commercially available program GraphPad Prism 4 was used for statistical 
analysis. Simple group comparisons were performed using the two-tailed unpaired t 
test. If more than two groups were compared, an ANOVA was performed followed by 
Bonferroni post hoc analysis. The level of significance was set at p < 0.05. All data 
are presented as mean + SEM. 
RESULTS 
DRR1 mRNA expression in the adult mouse brain 
DRR1 mRNA is widely expressed in the whole adult mouse brain (Figure 1; S1; S2; 
Table 1)   with a distinct neuroanatomical expression intensity profile. From anterior 
to posterior relative to bregma, the strongest DRR1 mRNA expression was detected 
in the posterior part of the lateral septum; the subfornical organ; the cell bodies of the 
pyramidal CA3 region of the hippocampus, specifically the CA3a and initial part of 
CA3b subfield; and cells ensheathing the stalk of the habenular commissure and the 
Purkinje cell layer of the cerebellum.  
Moderate DRR1 gene expression was visible, but not uniformly distributed, 
throughout the cortex. Especially high expression was detected in the primary 
somatosensory cortex and the retrosplenial cortex (both granular and agranular part). 
Interestingly, the cortical layer V (the inner pyramidal layer) displayed lower DRR1 
mRNA expression compared to the other cortical layers. Moderate DRR1 expression 
was also found in the lateral part of the caudate putamen, the amygdala, the 
mammillary nuclei and several thalamic (ventromedial hypothalamic nucleus and the 
parafascicular thalamic nucleus) and hypothalamic nuclei.  
Only very weak DRR1 mRNA expression was visible in the mesencephalon and the 
rhombencephalic medulla oblongata and pons.  
Whereas weak to strong DRR1 expression was found in neuronal tissue throughout 
the brain, DRR1 mRNA expression was less observed in white matter structures like 
the anterior commissure, the corpus callosum, the cerebral peduncle and the optic 
tract. We can observe a punctate pattern in 
the high resolution silver grain stained DRR1 mRNA images; however, intensity of 
the signal provided by the autoradiograph is almost undetectable. Interestingly, the 
expression of DRR1 mRNA was also detected in the choroid plexus and in 
ependymal cells of the brain ventricles, similar to Fam107B (Masana et al. 2015). 
Neuroanatomical distribution of DRR1 protein 
The neuroanatomical distribution of DRR1 protein was assessed by 
immunofluorescence. DRR1 protein could be found throughout all the adult mouse 
brain, with high expression in specific regions (Table 1, Figure 2 and 3).  
The DRR1 protein abundance in the septum nicely followed the pattern of mRNA 
expression with high DRR1 protein levels in the lateral septum. Moreover, also the 
caudate putamen, lateral globus pallidus, ventral pallidum as well as the nearby bed 
nucleus of the anterior commissure and the bed nucleus of the stria terminalis were 
DRR1 positive (Figure 2a). 
Within the cortex, DRR1 was found throughout all regions and layers of the cortex 
(Figure 2b). Immunofluorescence outlines neuronal cell bodies of cortical neurons 
(arrows in Fig 2 b1) but was also located to the surrounding neuropil. Particularly high 
density of DRR1 signal could be observed in layer IV of the barrel field, where it 
appears in barrel like structures (Figure 2 b2). Whereas the mRNA signal was clearly 
reduced within layer V of the cortex, DRR1 protein is not. Comparable levels of 
DRR1 protein were also found in the amygdala (Figure 2 b4). 
Moreover, strong DRR1 protein expression was present in the hippocampus and the 
adjacent habenular commissure (Figure 2 c1-c2). High protein levels could be found 
prominently in CA3 cell bodies but also in the dentate gyrus and the molecular layers. 
Additionally, cells covering the stalk of the habenular commissure were positive for 
both DRR1 mRNA and protein (Table 1 and Figure 2 c2). 
The cerebellum was one of the brain regions with the highest DRR1 protein level. 
DRR1 protein signal was strong in the Purkinje layer (cell bodies) and molecular layer 
of the cerebellum (Figure 2 c3). Because very strong mRNA expression of DRR1 was 
only visible in the Purkinje cell layer, it is likely that most of the DRR1 protein in the 
molecular layer belongs to Purkinje cell dendrites.  
The distribution of DRR1 protein in the thalamus and hypothalamus is summarized in 
Table 1. Several nuclei showed moderate DRR1 protein levels as indicated. High 
DRR1 abundance could be observed in the mammillary nuclei while the 
paraventricular nucleus of the hypothalamus showed only basal levels of DRR1. 
Interestingly, most of the circumventricular organs (CVOs) were strongly labeled by 
DRR1 immunofluorescence (Figure 3). High levels of DRR1 could be observed in the 
vascular organ of the lamina terminalis, the area postrema, the subfornical organ and 
the subcommissural organ, but not the median eminence. A broader definition of 
CVOs includes also the choroid plexus, which showed prominent DRR1 mRNA and 
protein (Table 1, Figure 3g). Also nuclei known to be highly interconnected with the 
CVOs, the supraoptic nucleus (data not shown) and the median preoptic nucleus 
(Figure 2 a3), do express DRR1.  
DRR1 was prominently but not exclusively located to neurons, as it is found in 
virtually all neurons but also in non-neuronal tissue like in the cells of the choroid 
plexus and the ependyma (Figure. 3g-h). 
 
Cellular localization of DRR1 protein 
DRR1 protein appeared in a punctate pattern independent of the neuroanatomical 
region and the intracellular localization (Figure 2, Figure 3). DRR1 was found in the 
neuropil as well as in the neuronal somata including the nuclei, where it shows 
denser signal. DRR1 was also located to cellular specializations as it was found in 
cilia of ependymal cells (Figure 3h). 
Furthermore DRR1 might be located to both presynaptic and postsynaptic structures 
(Figure S1). DRR1 co-localize with some of the Synapsin and PSD-95 labeled 
structures. Thus, DRR1 appears to be a putative but not integral part of synaptic 
structures. 
 
Glucocorticoids increase DRR1 mRNA in grey and white matter of the adult 
mouse brain  
The GR agonist dexamethasone (10 mg/Kg s.c.) increased DRR1 mRNA throughout 
the whole adult mouse brain, as shown in the representative autoradiographs of 
[35S]- labelled DRR1 mRNA (Figure 4a) and densitometric analysis (Figure 4b).  
Under basal conditions, DRR1 mRNA showed maximum expression (in arbitrary 
units, a.u.) in the hippocampal CA3 region (79 ±6), followed by the lateral septum (48 
±3) and the primary somatosensorial cortex-Barrel field (49 ±6), motor cortex (40 ±5), 
striatum (25 ±2) and with low (almost undetectable) expression in white matter fiber 
tracts such as the anterior commissure (12 ±3) and corpus callosum (12 ±3).  
After glucocorticoid receptor activation, DRR1 mRNA levels increased significantly 
(Student t-test) in all DRR1-rich regions but also in white matter regions. In detail, 
dexamethasone treatment increased mRNA expression in grey matter approximately 
136% in the hippocampal CA3 region, 186% in the lateral septum, 145% in the 
primary somatosensorial cortex-Barrel field, 152% in the motor cortex and 195% in 
the striatum; while in fiber tracts increased 436% in the anterior commissure and 
401% in the corpus callosum, reaching similar levels to neighboring areas such as 
striatum and cortex. Within the hippocampus, we could observe qualitatively 
increases in all CA3, DG and CA1 pyramidal neurons, and also in the str. Lac/mol 
and Str. Moleculare, and hilus, but this increase was less evident in the str. 
Radiatum. Within the cortex, DRR1 mRNA expression increased in all areas, with the 
somatosensory barrel field area showing the maximum expression. Moreover, the 
differential expression intensity pattern through the different cortical layers was 
maintained after dexamethasone treatment, with higher expression in layer IV and 
low expression in layer V.  
Interestingly, DRR1 was also strongly increased in the epithelium surrounding 
hippocampus, around ventricles and in the choroid plexus.  
 
Glucocorticoids increase DRR1 in the membrane fraction 
DRR1 protein levels were increased by dexamethasone (10 mg/kg s.c.) treatment 
compared to vehicle in the mouse hippocampus, and at greater extent in membrane 
rich fractions. Dexamethasone increased total protein expression of DRR1 in the 
hippocampus (Figure 5a) (p<0.0001 vs actin; p<0.05 vs tubulin) but not in the 
cerebellum (data not shown) when compared to vehicle treated mice (n=6 
mice/group).  
Subcellular fractioning of hippocampal dissected tissue showed that DRR1 is 
expressed ubiquitously in the cell and dexamethasone increased DRR1 protein 
expression significantly in the membrane (F2) (p<0.05), but not cytosol (F1), nuclei 
(F3) or cytoskeleton fractions (F4) (Figure 5b) compared to vehicle treated mice (n=6 
mice/group). Second subcellular fractioning showed that dexamethasone increased 
DRR1 in the crude membrane fraction (P2) (p<0.05), cytosol (S2) (p<0.05), 
postsynaptic membrane fraction (triton insoluble fraction, TIF) (p<0.05) and triton 
soluble fraction (TSF) (p<0.05) (when normalized to tubulin; all of them when 
normalized to actin (not shown)) (Figure 5c). In all experiments corticosterone levels 
were measured and were significantly reduced in dexamethasone treated mice 
compared to vehicle:  46.8 ±10.6 and 0.7 ± 0.3 ng/ml for the total protein/subcellular 
fraction experiment in Veh and DEX treated mice, respectively (n=11-12 mice/group); 
and 66.6 ± 10.6 and 1.2 ± 1.3 ng/ml for the alternative subfraction procedure in Veh 
and DEX treated mice, respectively (n=16 mice/group). Corticosterone levels were 
measured and were significantly reduced in dexamethasone treated mice compared 




The characterization of molecular targets able to modulate stress resilience is 
fundamental in the search for treatments of stress-related disorders. The stress-
inducible DRR1 was recently proposed as a novel molecular player able to modulate 
and attenuate the aversive consequences of stress (Masana et al. 2014; van der 
Kooij et al. 2016). In the present study, we provide a comprehensive description of 
the neuroanatomical expression of DRR1 in the adult mouse brain and its regulation 
by glucocorticoids. Our results indicate that DRR1 is ubiquitously expressed in the 
cell and specifically expressed in distinct brain regions under basal conditions. In 
addition, glucocorticoids increase DRR1 expression in membrane rich structures in 
the cell and throughout the whole brain, showing greater increase in white matter 
tracts, where it is not detected under baseline conditions.  
DRR1 is expressed in radial glia during development (Pollen et al. 2015), and later in 
neurons, astrocytes and oligodendrocytes (Cahoy et al. 2008; Masana et al. 2014; 
Hochgerner et al. 2018), with particularly strong upregulation and most highly 
expressed in late developing astrocytes (Cahoy et al. 2008). Here, we further extend 
the characterization of expression of DRR1 to non-neuronal tissue such as the 
choroid plexus and ependyma. These data indicate that glucocorticoids could 
modulate the physiology of both neuronal and non-neuronal brain cells through the 
modulation of DRR1 expression, probably by modulating actin reorganization and 
dynamics using similar mechanisms (Le et al. 2010; Schmidt et al. 2011).  
In addition, DRR1 is ubiquitously expressed throughout the cell. This is shown by the 
expression of DRR1 in all the different subcellular fractions and the pattern of 
expression detected by immunohistochemistry, where the punctate DRR1 pattern 
can be found inside and around the nucleus and also the neuropil, as previously 
described for the lateral septum (Masana et al. 2014). This expression pattern is 
confirmed in other brain regions, and is especially clear in the cerebellum, where 
DRR1 is strongly expressed in the soma and dendrites of Purkinje cells. The 
presence of DRR1 protein in regions where mRNA expression is lacking is 
suggestive of DRR1 expression in distant axons and/or dendrites and is consistent 
with the expression of DRR1 in axonal projections found in mouse development 
(Asano et al. 2010). Another example would be layer V of the cortex, where nearly no 
mRNA signal was observed under both basal and dexamethasone stimulation, but 
showed protein expression. These data, together with the expression of DRR1 
protein in membrane rich-structures and in the synapse, suggests that DRR1 is 
expressed in dendrites and/or axons, In addition, DRR1 is expressed in TIF and TSF 
fractions and partially co-localizes with synapsin and PSD95, indicating that DRR1 is 
a putative but not integral part of synaptic structures. 
In the brain, DRR1 is expressed in CVOs, suggesting its potential role in the 
regulation of brain homeostasis (Denton et al. 1996). Interestingly, CVOs lack the 
blood brain barrier and thus circulating blood can penetrate directly to the brain 
through the fenestrated vessels (Sisó et al. 2010). Moreover, the presence of DRR1 
in cilia from epithelial cells further suggests that DRR1 containing structures could be 
relevant for sensory information from the cerebrospinal fluid (Singla and Reiter 2006) 
 through changes in cytoskeletal structure and/or dynamics. Interestingly, cilia and 
 through changes in cytoskeletal structure and/or 
dynamics. Interestingly, cilia and dendrites show structural similarities (Nechipurenko 
et al. 2013), suggesting similar functions in neurons. In this line,
DRR1 is expressed strongly in layer IV of the somatosensory barrel field, whose 
barrel neurons are the major target for somatosensory inputs from the thalamus 
(Schubert et al. 2003). The lateral septum has also a key role in integrating 
information from affective brain regions, especially from hippocampus and 
hypothalamus among others (Sheehan et al. 2004). ImportantlyAlso, the 
hypothalamus, where DRR1 expression is strongly induced by dexamethasone in 
hypothalamic neural-progenitor/stem cells derived from mouse embryosneural 
embryonic stem cells (Frahm et al. 2016, 2017), integrates inputs from many central 
and peripheral sources to maintain homeostasis of different organ systems and 
whole body metabolism (Denton et al. 1996), further indicating a role of DRR1 in 
sensory integration.  
Glucocorticoid receptor activation is able to increase the mRNA expression in almost 
all brain regions, except for few regions such as layer V from cortex or stratum 
radiatum in the hippocampus, where DRR1 mRNA expression is also not detected 
under baseline conditions. However, it is particularly intriguing that DRR1 expression 
is increased by glucocorticoids especially in white matter tracts
, i.e. corpus callosum, anterior commissure. One possible explanation is that DRR1 
, i.e. corpus 
callosum, anterior commissure. One possible explanation is that DRR1 
mRNA could be strongly induced in oligodendrocytes, where DRR1 is lowly 
expressed under baseline conditions (Cahoy et al. 2008), and/or a consequence of 
an increase in corticosteroid-induced oligodendrogenesis (Chetty et al. 2014). In this 
line, glucocorticoid receptor expression is especially strong in white matter tracts in 
the adult mouse (Quinn et al. 2016). Another possibility is that DRR1 mRNA is 
transported to the terminal, as for example the actin-regulating protein Arc (Huang et 
al. 2007). Accordingly, stress-induced DRR1 protein expression is increased in 
membrane structures, but not in the nucleus. However, changes in the ratio of G-/F-
actin in the cytosol could modulate serum response factor responsiveness (Olson 
and Nordheim 2010; Knöll 2011). Thus, stress might indirectly modulate gene 
transcription of immediate early genes and of actin cytoskeleton genes through 
DRR1 changes. 
In conclusion, we provide further evidence that the actin interacting protein DRR1 
expression, whose expression is induced by glucocorticoids, especially in membrane 
rich structures and white matter tracts, might be involved in the modulation of how the 
cells sense and integrate signals from the environment. As glucocorticoids-mediated 
mechanisms are prominent in the late phase response to stress (de Kloet et al. 
2005), DRR1 induction could be involved in homeostasis restoration after stress and 
the storage of information in preparation for future use. However, stress disorders are 
more prevalent in women than in men, thus, further studies comparing male and 
female DRR1 expression and regulation by glucocorticoids should be addressed for 
translational relevance. Finally, these data might be a useful to understand DRR1 
dependent physiology and to extend the knowledge on stress resilience mechanisms 
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Figure 1. DRR1 mRNA showed distinct expression throughout the adult mouse 
brain. (a) Representative autoradiograms of [35S]-labeled DRR1 coronal brain 
sections from the same mouse at different anterioposterior (AP) location in relation to 
bregma. (b-e) High resolution photomicrographs showing the expression pattern of 
DRR1 mRNA revealed by silver grain staining under dark-field illumination. Pictures 
show mosaics of several photomicrographs at (b) AP: -0.3; (c) AP: 1.8; (d) 2.5 and 
(e) 5.5 mm from bregma (Paxinos and Franklin 2008). Abbreviations: (aca) anterior 
commissure, (cc) corpus callosum, (CA3) cornu ammonis 3, (fr) fasciculus 
retroflexus, (hbc) habenular comissure, (ic) inferior colliculus, (LS) lateral septum, 
(LV) lateral ventricle, (MM) mammillary nucleus, (Mo) molecular layer of the 
cerebellum, (Nu) nuclear layer of the cerebellum, (PF) parafascicular thalamic 
nucleus, (Pn) pontine nuclei, (P) Purkinje cell layer of the cerebellum, (RS) 
retrosplenial cortex and (3V) third ventricle. 
 
Figure 2. DRR1 protein is expressed in specific regions throughout the entire adult 
mouse brain. Representative confocal images show immunofluorescence of DRR1 
(red) and NeuN (green) or DAPI (blue) from (a) the striatal and septal region (0.2 to -
0.1 mm from bregma), (b) cerebral cortex and amygdala region (-0.7 mm from 
bregma) and (c) hippocampal and cerebellar regions (-1.8 and -5.5 mm from bregma, 
respectively). Specifically, expression of DRR1 was found in the lateral septum (a1, 
a3), striatum (a2), median preoptic nucleus (a3), bed nucleus of the anterior 
commissure and subfornical organ (a4), primary motor cortex (b1), barrel field (b2), 
secondary somatosensory cortex (b3), amygdala (b4), hippocampus (c1), habenular 
commissure (c2) and purkinge cell layer and molecular layer of the cerebellum (c3). 
Abbreviations: (aca) anterior commissure anterior part, (BAC) bed nucleus of the 
anterior commissure, (BLA) basolateral amygdaloid nucleus, (BST) bed nucleus of 
the stria terminalis, (CA1) cornu ammonis 1, (CA3) cornu ammonis 3,  (cc) corpus 
callosum, (Ce) central amygdaloid nucleus, (CPu) caudate putamen, (Cx) cortex, 
(D3V) dorsal 3rd ventricle, (DG) dentate gyrus, (f) fornix, (gl) granular layer of the 
cerebellum, (GrDG) granular layer of the DG, (LMol) lacunosum moleculare layer, 
(hbc) habenular commissure, (LS) lateral septal nucleus, (MHb) medial habenular 
nucleus, (LHb) lateral habenular nucleus, (MnPO) median preoptic nucleus, (ml) 
molecular layer of the cerebellum, (Mol) molecular layer, (Or) oriens layer, (PoDG) 
polymorph layer of the dentate gyrus, (pl) Purkinje cell layer of the cerebellum, (Py) 
pyramidal cell layer, (Rad) stratum radiatum, (SFi) septofimbrial nucleus, (SFO) 
subfornical organ.   
 
Figure 3. DRR1 protein is expressed in most of the circumventricular organs.  (a) 
Schematic overview of the location of the different circumventricular organs in the 
mouse brain. Representative confocal images show immunofluorescence of DRR1 
(red) and DAPI (blue) from (b) the subfornical organ (0.8 mm posterior to bregma), 
(c) the subcommissural organ (2.5 mm posterior to bregma), (d) the vascular organ of 
the lamina terminalis (0.50mm anterior to bregma), (f) the area postrema, (1.7mm 
posterior to bregma) (e) but not the median eminence. DRR1 protein can also be 
found in non-neuronal cells of (g) the choroid plexus and the ventricle ependyma. (h)  
In some rare cases, DRR1 was found in cilia of ependymal cells. Abbreviations: (3V) 
3rd ventricle, (AP) area postrema, (chp) choroid plexus, (hbc) habenular commissure, 
(ME) median eminence, (OVLT) vascular organ of the lamina terminalis, (SCO) 
subcommissural organ, (SFO) subfornical organ.  
Figure 4. The glucocorticoid-agonist dexamethasone increased DRR1 mRNA 
expression in grey matter and fiber tracts. (a) Representative in situ hybridization 
autoradiographs of [35S]- labelled DRR1 mRNA of mice injected with Dexamethasone 
(DEX)(10 mg/Kg s.c.) or vehicle (Veh). (b) Densitometric quantification of 
Dexamethasone-induced DRR1 mRNA expression compared to vehicle. Bars show 
mean ± SEM of gray values in arbitrary units (a.u.). **p < 0.001 and  ***p < 0.0001 vs 
vehicle (t test). Abbreviations: (CA3) cornu ammonis 3, (cc) corpus callosum, (CPu) 
caudate putamen, (LS) lateral septal nucleus, (S1B) primary somatosensory cortex - 
Barrel field 
 
Figure 5. Dexamethasone (10 mg/Kg s.c.) mostly increases DRR1 protein 
expression close to the membrane. DRR1 protein levels were measured in the 
mouse hippocampus by Western Blot. (a) Total DRR1 protein levels, (b) DRR1 
protein levels in the cytosol (F1), membranes (F2), nuclear (F3) and cytoskeletal (F4) 
subcellular fractions; and (c) DRR1 protein levels in nuclei-associated membranes 
(P1), crude membrane fraction (P2), cytosol (S2), triton insoluble fraction (TIF) and 
triton soluble fraction (TSF). Actin and tubulin were used as loading control. Bars 
show mean ± SEM ratios of DRR1/tubulin and DRR1/actin grey levels. *p < 0.05 **p 
< 0.001 and ***p < 0.0001 vs vehicle (t test). 
 
Figure S1: Synaptic localization of DRR1 protein. (a) DRR1 protein (green) can 
be found throughout the CA3 region within the cells of the pyramidal layer as well the 
stratum lucidum (SLu) and the stratum oriens (Or), whereas Synapsin (red) is located 
to the neuropil of SLu and Or. DRR1 is partly colocalized with Synapsin on both the 
Or (b) and SLu (c), as indicated (arrows). Colocalization of DRR1 and PSD-95 is 
shown (arrows) for SLu (d) and Or (e). 
TABLES 
Table 1. DRR1 expression in the mouse brain 




Cortex   
Layer I ++ ++ 
Layer II ++ ++ 
Layer III ++ ++ 
Layer IV ++ +++ 
Layer V -/+ ++ 
Layer VI ++ ++ 
   
Hippocampal region   
CA3 +++ ++ 
CA2 + + 
CA1 + + 
Granular layer of the dentate gyrus + + 
Polymorhic layer of the dentate gyrus + + 
Molecular layer of the dentate gyrus + ++ 
stratum lacunosum-moleculare + ++ 
Stratum radiatum - + 
   
Septal region   
Lateral septal nucleus +++ ++ 
Medial septal nucleus ++ ++ 
Septohippocampal nucleus ++ ++ 
Septofimbrial nucleus + + 
Bed nucleus of anterior commissure n/a ++ 
Median preoptic nuncleus n/a ++ 
   
Basal ganglia and related areas   
Caudate putamen ++ ++ 
Globus pallidus + ++ 
Bed nucleus of the stria terminalis + ++ 
Substantia nigra - + 
Subthalamic nucleus + ++ 
   
Thalamus   
Habenular nuclei + ++ 
Habenular commissure +++ +++ 
Reuniens thalamic nucleus + ++ 
Parafascicular thalamic nucleus ++ ++ 
Zona incerta ++ ++ 
Ventral pallidum + ++ 
Posterior thalamic nuclear group + ++ 
Dorsal/ventral lateral geniculate 
nucleus 
+ ++ 
Bed nucleus of the stria terminalis + ++ 
   
   
   
Table 1 cont.   




Hypothalamus   
Paraventricular hypothalamic nucleus + + 
Peri-PVN region + + 
Ventromedial hypothalamic nucleus ++ + 
Lateral mammillary nucleus +++ +++ 
Medial mammillary nucleus +++ +++ 
Supraoptic nucleus n/a ++ 
Arcuate hypothalamic nucleus ++ ++ 
Suprachiasmatic nucleus ++ ++ 
   
Amygdaloid complex   
Basolateral amygdaloid nucleus ++ ++ 
Basomedial amygdaloid nucleus ++ ++ 
Central amygdaloid nucleus + ++ 
   
Circumventricular organs   
Subfornical organ +++ +++ 
Subcommissural organ - ++ 
Organum vasculosum lamina 
terminalis 
n/a ++ 
Median eminence - + 
Pituitary n/a n/a 
Area postrema n/a ++ 
   
Cerebellum   
Purkinje cell layer +++ +++ 
Molecular layer ++ +++ 
Granular layer + + 
   
White matter structures   
Corpus callosum + + 
Anterior commissure - + 
Fornix - + 
Optic tract - ++ 
Ventral hippocampal commissure - + 
Cerebral peduncle - + 
   
Non neuronal tissue   
Choroid plexus ++ ++ 
Ventricular Ependymal cells ++ ++ 
 
Relative expression levels of DRR1 mRNA and protein in adult mouse brain is 
expressed in the following four categories: - not detectable, + weak signal, ++ 
moderate signal and +++ strong signal, mRNA expression levels was classified into 
four categories according to intensity levels of mRNA expression in autoradiographs  
and photomicrographs (Figure 1, S1, S2). The Oonly regions that could be clearly 
assigned in regard of DRR1 mRNA or protein expression were included. 
